|
46 Companies |
|
12 Products |
|
12 Products |
|
17 Mechanisms of Action |
|
756 Trials |
|
22406 News |
|
| «12...390391392393394395396397398399400...401402» |
- | New trial: Exercise Intervention - and Impact on Hospitalization (clinicaltrials.gov) - Apr 10, 2017
P=N/A, N=32, Recruiting, Sponsor: Mayo Clinic
- | New trial, IO biomarker: Strength and Aerobic Training in Elderly Lymphoma Patients During Chemotherapy and Its Impact on Treatment Outcomes, Patients Functioning and Biological Markers of Aging (clinicaltrials.gov) - Apr 4, 2017
P=N/A, N=100, Not yet recruiting, Sponsor: Rabin Medical Center
- | Trial completion, Enrollment change, Trial primary completion date: Calorie Restriction With Leucine Supplementation (clinicaltrials.gov) - Mar 27, 2017
P=N/A, N=43, Completed, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed | N=75 --> 43 | Trial primary completion date: Jul 2017 --> Mar 2017
- | Trial completion, Trial primary completion date: Calorie Restriction, Protein Supplementation and Metabolic Health (clinicaltrials.gov) - Mar 27, 2017
P=N/A, N=75, Completed, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed | N=75 --> 43 | Trial primary completion date: Jul 2017 --> Mar 2017 Recruiting --> Completed | Trial primary completion date: Jul 2017 --> Mar 2017
- || bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly
Trial primary completion date: Dose Range Finding Study of Bimagrumab in Sarcopenia (clinicaltrials.gov) - Mar 15, 2017
P2, N=280, Recruiting, Sponsor: Novartis Pharmaceuticals
Recruiting --> Completed | Trial primary completion date: Jul 2017 --> Mar 2017 Trial primary completion date: Mar 2018 --> Dec 2018
- | losartan / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: A Study of Muscle Strength Maintenance in Older Adults (clinicaltrials.gov) - Mar 15, 2017
P2, N=37, Completed, Sponsor: Johns Hopkins University
Trial primary completion date: Mar 2018 --> Dec 2018 Recruiting --> Completed | N=24 --> 37 | Trial primary completion date: Jul 2016 --> Oct 2016
- | Phase classification, HEOR: Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy (clinicaltrials.gov) - Mar 14, 2017
P=N/A, N=60, Recruiting, Sponsor: Brazilian National Cancer Institute
Recruiting --> Completed | N=24 --> 37 | Trial primary completion date: Jul 2016 --> Oct 2016 Phase classification: P2 --> P=N/A
- | New trial: Microbiome and Sarcopenia in Patients With Liver Cirrhosis (clinicaltrials.gov) - Mar 14, 2017
P=N/A, N=120, Not yet recruiting, Sponsor: Medical University of Graz
- | New trial: PVHA: Detraining in People Living With HIV/AIDS (clinicaltrials.gov) - Mar 9, 2017
P=N/A, N=2, Completed, Sponsor: Universidade Federal do Rio Grande do Norte
- | Enrollment closed, Enrollment change: Diet and Exercise Interventions to Increase Muscle Strength and Function (clinicaltrials.gov) - Mar 7, 2017
P=N/A, N=94, Active, not recruiting, Sponsor: South Dakota State University
Phase classification: P2 --> P=N/A Not yet recruiting --> Active, not recruiting | N=200 --> 94
- | Biomarker, Trial primary completion date: HAPPY: A Prospective Cohort Study of Aged People for Chronic Diseases (clinicaltrials.gov) - Feb 27, 2017
P=N/A, N=1000, Recruiting, Sponsor: Seoul National University Bundang Hospital
Not yet recruiting --> Active, not recruiting | N=200 --> 94 Trial primary completion date: Jun 2017 --> Dec 2017
- | Trial primary completion date, Surgery: Analysis of Body Composition in Relation to Outcome After Surgery in a Cohort of Patients With Esophageal Cancer (clinicaltrials.gov) - Feb 24, 2017
P=N/A, N=76, Active, not recruiting, Sponsor: Vastra Gotaland Region
Trial primary completion date: Jun 2017 --> Dec 2017 Trial primary completion date: Jan 2010 --> Nov 2010
- | New trial: Roles of Uremic Toxins in Uremic Sacropenia (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=300, Not yet recruiting, Sponsor: Tungs
- | testosterone gel / Generic mfg.
Trial termination: TOM: Testosterone in Older Men With Sarcopenia (clinicaltrials.gov) - Feb 23, 2017
P4, N=209, Terminated, Sponsor: Boston Medical Center
Completed --> Terminated; Higher incidence of cardiovascular events in the testosterone arm of the trial. Decision taken by the DSMB on December 31st, 2009.
- | New trial: Sarcopenia and Visceral Obesity in Esophageal and Gastric Cancer (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=500, Active, not recruiting, Sponsor: St. James's Hospital, Ireland
- | New trial: UNITS: The Urinary Incontinence Treatment Study (clinicaltrials.gov) - Feb 19, 2017
P=N/A, N=100, Recruiting, Sponsor: Wake Forest University Health Sciences
- | Trial completion, Enrollment change: Prevalence and Determinants of Sarcopenic Obesity in Taiwanese Dialysis Patients (clinicaltrials.gov) - Feb 17, 2017
P=N/A, N=70, Completed, Sponsor: Tungs
Decision taken by the DSMB on December 31st, 2009. Not yet recruiting --> Completed | N=500 --> 70
- goserelin acetate / Generic mfg.
New P3 trial: Systemic Hormones and Muscle Protein Synthesis (clinicaltrials.gov) - Feb 15, 2017
P3, N=32, Recruiting, Sponsor: University of Nottingham
- Phase classification: SPRINTT: Multicomponent Intervention for Physical Frailty and Sarcopenia (clinicaltrials.gov) - Feb 2, 2017
P=N/A, N=1500, Recruiting, Sponsor: Catholic University of the Sacred Heart
Not yet recruiting --> Completed | N=500 --> 70 Phase classification: P3 --> P=N/A
- Trial completion, Enrollment change, HEOR: Nutrition, Exercise, and Breast Cancer Survivorship (clinicaltrials.gov) - Feb 1, 2017
P=N/A, N=14, Completed, Sponsor: Baltimore VA Medical Center
Phase classification: P3 --> P=N/A Active, not recruiting --> Completed | N=100 --> 14
- Trial primary completion date: Calorie Restriction, Protein Supplementation and Metabolic Health (clinicaltrials.gov) - Jan 30, 2017
P=N/A, N=75, Recruiting, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed | N=100 --> 14 Trial primary completion date: Dec 2016 --> Jul 2017
- || Trial primary completion date: Calorie Restriction With Leucine Supplementation (clinicaltrials.gov) - Jan 30, 2017
P=N/A, N=75, Active, not recruiting, Sponsor: Washington University School of Medicine
Trial primary completion date: Dec 2016 --> Jul 2017 Trial primary completion date: Dec 2016 --> Jul 2017
- New trial, Surgery: Analysis of Body Composition in Relation to Outcome After Surgery in a Cohort of Patients With Esophageal Cancer (clinicaltrials.gov) - Jan 26, 2017
P=N/A, N=76, Active, not recruiting, Sponsor: Vastra Gotaland Region
- valsartan / Generic mfg.
Enrollment change, Trial termination: Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients (clinicaltrials.gov) - Jan 26, 2017
P2, N=1, Terminated, Sponsor: Wake Forest University Health Sciences
Trial primary completion date: Dec 2016 --> Jul 2017 N=40 --> 1 | Recruiting --> Terminated; Change in study design and inability to recruit participants
- New trial: Lysosomal Movement and Anabolic Resistance (clinicaltrials.gov) - Jan 25, 2017
P=N/A, N=26, Not yet recruiting, Sponsor: University of Birmingham
- New trial: An OBServational Clinical Trial (SARA-OBS) in Sarcopenia and Sarcopenic Obesity in Patients Aged 65 Years and Over (clinicaltrials.gov) - Jan 17, 2017
P=N/A, N=300, Not yet recruiting, Sponsor: Biophytis
- Trial primary completion date: Carnitine Supplementation and Skeletal Muscle Function (clinicaltrials.gov) - Jan 10, 2017
P2/3, N=40, Active, not recruiting, Sponsor: Gdansk University of Physical Education and Sport
N=40 --> 1 | Recruiting --> Terminated; Change in study design and inability to recruit participants Trial primary completion date: Nov 2016 --> Feb 2017
- New trial: Efficacy of an Intervention to Prevent Frailty in Obese Elderly People (PRE-FROB) (clinicaltrials.gov) - Dec 22, 2016
P=N/A, N=360, Not yet recruiting, Sponsor: Consorci Sanitari del Maresme
- Biomarker, Enrollment open, Trial primary completion date: A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy (clinicaltrials.gov) - Dec 20, 2016
P=N/A, N=30, Recruiting, Sponsor: University of Florida
Trial primary completion date: Nov 2016 --> Feb 2017 Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2017 --> Apr 2018
- Enrollment open, Enrollment change, Trial primary completion date: Citrulline Supplementation Combined With Exercise: Effect on Muscle Function in Elderly People (CITEX Study) (clinicaltrials.gov) - Dec 16, 2016
P1/2, N=160, Recruiting, Sponsor: Universite du Quebec a Montreal
Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2017 --> Apr 2018 Not yet recruiting --> Recruiting | N=64 --> 160 | Trial primary completion date: Jun 2018 --> Dec 2017
- New trial: Cause and Importance of the Age-dependent Sarcopenia (clinicaltrials.gov) - Dec 15, 2016
P=N/A, N=150, Recruiting, Sponsor: Charite University, Berlin, Germany
- Trial completion: Nutrition and Exercise for Sarcopenia (clinicaltrials.gov) - Dec 12, 2016
P1, N=108, Completed, Sponsor: The University of Texas Medical Branch, Galveston
Not yet recruiting --> Recruiting | N=64 --> 160 | Trial primary completion date: Jun 2018 --> Dec 2017 Active, not recruiting --> Completed
- tilarginine (L-NMMA) / Arginox Pharma, Houston Methodist Research Institute
Trial completion: Insulin and Sarcopenia in the Elderly (clinicaltrials.gov) - Dec 12, 2016
P1, N=88, Completed, Sponsor: The University of Texas Medical Branch, Galveston
Active, not recruiting --> Completed Terminated --> Completed
- Trial completion, Enrollment change: Omega-3 Supplementation and Resistance Training (clinicaltrials.gov) - Dec 1, 2016
P=N/A, N=24, Completed, Sponsor: University of Manitoba
Terminated --> Completed Recruiting --> Completed | N=20 --> 24
- New trial, Metastases: Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients (clinicaltrials.gov) - Dec 1, 2016
P=N/A, N=94, Recruiting, Sponsor: Instituto Nacional de Cancerologia de Mexico
- Biomarker, New trial: Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma (clinicaltrials.gov) - Nov 30, 2016
P=N/A, N=114, Completed, Sponsor: Institut de Canc
- Trial completion: Preventive Physiotherapy Intervention in Elderly People With Sarcopenia (clinicaltrials.gov) - Nov 22, 2016
P=N/A, N=70, Completed, Sponsor: University of Valencia
Recruiting --> Completed | N=20 --> 24 Active, not recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: Impact of Chronic Disease Control and Aging Psychology on Outcomes of Frailty-Sarcopenia Syndrome in Ambulatory Geriatric Patients (clinicaltrials.gov) - Nov 10, 2016
P=N/A, N=151, Completed, Sponsor: National Taiwan University Hospital
Active, not recruiting --> Completed Recruiting --> Completed | N=250 --> 151 | Trial primary completion date: Dec 2016 --> Aug 2016
- Trial primary completion date: The Strong Brain Study (clinicaltrials.gov) - Nov 9, 2016
P=N/A, N=40, Recruiting, Sponsor: University of Florida
Recruiting --> Completed | N=250 --> 151 | Trial primary completion date: Dec 2016 --> Aug 2016 Trial primary completion date: Sep 2016 --> Jun 2017
- Trial completion, Trial primary completion date, PARP Biomarker: Skeletal Muscle Apoptosis and Physical Performance; Oxidative RNA/DNA Damage and Repair in Aged Human Muscle (clinicaltrials.gov) - Nov 3, 2016
P=N/A, N=63, Completed, Sponsor: University of Florida
Trial primary completion date: Sep 2016 --> Jun 2017 Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Jul 2016
- Trial primary completion date: Carnitine Supplementation and Skeletal Muscle Function (clinicaltrials.gov) - Oct 26, 2016
P2/3, N=40, Active, not recruiting, Sponsor: Gdansk University of Physical Education and Sport
Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Jul 2016 Trial primary completion date: Aug 2016 --> Nov 2016
- Trial completion: RESTORE-ME: Effects of a Resistance Training Program in Older Women With Sarcopenia (clinicaltrials.gov) - Oct 26, 2016
P=N/A, N=25, Completed, Sponsor: University of Rhode Island
Trial primary completion date: Aug 2016 --> Nov 2016 Active, not recruiting --> Completed
- New trial, Reimbursement: Implementing Resistance Exercise to Reduce Frailty for Older Adult (clinicaltrials.gov) - Oct 25, 2016
P=N/A, N=126, Not yet recruiting, Sponsor: Northwestern University
- || New P3 trial: Starting a Testosterone and Exercise Program After Hip Injury (clinicaltrials.gov) - Oct 18, 2016
P3, N=300, Not yet recruiting, Sponsor: Washington University School of Medicine
- Trial completion: SARCOPENIE: Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma (clinicaltrials.gov) - Oct 5, 2016
P=N/A, N=98, Completed, Sponsor: Centre Henri Becquerel
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open, Trial initiation date: MUSFAT: Muscle Loss and Fatigue as a Consequence of Radiotherapy (clinicaltrials.gov) - Oct 5, 2016
P=N/A, N=20, Enrolling by invitation, Sponsor: Essentia Health
Active, not recruiting --> Completed Not yet recruiting --> Enrolling by invitation | Initiation date: Oct 2015 --> Jan 2016
- || bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly
Trial primary completion date: Dose Range Finding Study of Bimagrumab in Sarcopenia (clinicaltrials.gov) - Sep 28, 2016
P2, N=280, Recruiting, Sponsor: Novartis Pharmaceuticals
Not yet recruiting --> Enrolling by invitation | Initiation date: Oct 2015 --> Jan 2016 Trial primary completion date: Aug 2017 --> Mar 2018
- New trial, HEOR: The Effectiveness of Lifestyle Intervention on Body Composition, Physical Performances and Quality of Life Among Elderly People in Long-term Care Facilities (clinicaltrials.gov) - Sep 22, 2016
P=N/A, N=123, Completed, Sponsor: Central Taiwan University of Science and Technology
- New P1 trial, HEOR: Exercise and Nutrition Interventions in Age-related Sarcopenia (clinicaltrials.gov) - Sep 22, 2016
P1, N=160, Recruiting, Sponsor: Liverpool Hope University
- Trial primary completion date: Screening for Age-Related Skeletal Muscle Dysfunction (clinicaltrials.gov) - Sep 22, 2016
P=N/A, N=30, Active, not recruiting, Sponsor: Washington D.C. Veterans Affairs Medical Center
Trial primary completion date: Aug 2017 --> Mar 2018 Trial primary completion date: Jun 2016 --> Jun 2017